跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Vimpat - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Vimpat
Approved
STANDARD
Vimpat
Aesica Pharmaceuticals GmbH
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
91a88b74c0e28f02
Company
Aesica Pharmaceuticals GmbH
Type
Standard
Approval Details
Approval Id
91a88b74c0e28f02
Drug Approval Philippines Name
Vimpat
Product Name
Vimpat
Registration Number
DR-XY43253
Brand Name
Vimpat
Generic Name
Lacosamide
Dosage Form
Film-Coated Tablet
Dosage Strength
100 mg
Manufacturer
Aesica Pharmaceuticals GmbH
Importer
Abbott Laboratories
Distributor
Abbott Laboratories
Company Detail Path
/organization/aesica-pharmaceuticals-gmbh
Importer Detail Path
/organization/abbott-laboratories
Distributor Detail Path
/organization/abbott-laboratories
Issuance Date
15 August 2024
Expiry Date
15 August 2029
Pharmacologic Category
Antiepileptic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
91a88b74c0e28f02
Type
Standard
Back to Philippines FDA Approvals